Literature DB >> 23559555

Neck spasm after chemoradiotherapy for head and neck cancer: natural history and dosimetric correlates.

Klaudia U Hunter1, Francis Worden, Carol Bradford, Mark Prince, Scott McLean, Gregory Wolf, Douglas B Chepeha, Avraham Eisbruch.   

Abstract

BACKGROUND: Little is known about the determinants of postradiation neck spasms in patients with head and neck cancer.
METHODS: Patients with head and neck cancer treated with radiation therapy (RT) from 2004 to 2010 who experienced neck spasms werereviewed. Radiation doses were generated for their sternocleidomastoid (SCM) muscles bilaterally. Unaffected SCMs were used as controls.
RESULTS: Thirty-four patients reported neck spasms. Thirty had received definitive chemoradiation, and 4 had RT alone. Seven also had an ipsilateral neck dissection. Median time to onset was 23 months (range, 6-67 months). There were significantly higher radiation doses to the affected SCMs with a median of the mean dose to the affected and unaffected SCM of 62.3 Gy (range, 29-71 Gy) and 53.7 Gy (range, 27-65 Gy), respectively (p < .0001). Other dosimetric variables were also statistically significant but were highly correlated with the mean SCM dose. Neck dissection did not affect our results.
CONCLUSION: Neck spasms after chemotherapy intensity-modulated radiation therapy (IMRT) shows a strong dose-response relationship.
Copyright © 2013 Wiley Periodicals, Inc.

Entities:  

Keywords:  complications; head and neck cancer; myoclonus; neck spasms; radiation

Mesh:

Year:  2013        PMID: 23559555     DOI: 10.1002/hed.23284

Source DB:  PubMed          Journal:  Head Neck        ISSN: 1043-3074            Impact factor:   3.147


  4 in total

Review 1.  Intensity-modulated radiotherapy for head and neck surgeons.

Authors:  Stanley I Gutiontov; Edward J Shin; Benjamin Lok; Nancy Y Lee; Ruben Cabanillas
Journal:  Head Neck       Date:  2015-12-26       Impact factor: 3.147

2.  Cervical nodal level V can safely be omitted in the treatment of locally advanced oropharyngeal squamous cell carcinoma with definitive IMRT.

Authors:  Stanley Gutiontov; Jonathan Leeman; Benjamin Lok; Paul Romesser; Nadeem Riaz; C Jillian Tsai; Nancy Lee; Sean McBride
Journal:  Oral Oncol       Date:  2016-05-27       Impact factor: 5.337

Review 3.  Management of locally advanced HPV-related oropharyngeal squamous cell carcinoma: where are we?

Authors:  Stuart E Samuels; Avraham Eisbruch; Jonathan J Beitler; June Corry; Carol R Bradford; Nabil F Saba; Michiel W M van den Brekel; Robert Smee; Primož Strojan; Carlos Suárez; William M Mendenhall; Robert P Takes; Juan P Rodrigo; Missak Haigentz; Alexander D Rapidis; Alessandra Rinaldo; Alfio Ferlito
Journal:  Eur Arch Otorhinolaryngol       Date:  2015-10-13       Impact factor: 3.236

4.  Patient- and treatment-related risk factors associated with neck muscle spasm in nasopharyngeal carcinoma patients after intensity-modulated radiotherapy.

Authors:  Lu-Lu Zhang; Guan-Qun Zhou; Zhen-Yu Qi; Xiao-Jun He; Jia-Xiang Li; Ling-Long Tang; Yan-Ping Mao; Ai-Hua Lin; Jun Ma; Ying Sun
Journal:  BMC Cancer       Date:  2017-11-23       Impact factor: 4.430

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.